The federal government has outlined procedures for federal employees to be compensated for any injuries they receive as a result of getting Covid-19 vaccines under President Biden’s mandate. According to a bulletin issued by the Federal Employees’ Compensation Program under […]
(READ) Bulletin: Federal employees to be compensated for Covid-19 vaccine injuries Read More »
An original analysis The following is an exclusive analysis of illnesses and disorders occurring after Covid-19 vaccination as reported to Vaccine Adverse Event Reporting System (VAERS), a federal database. It does not include all of the adverse events reported; it
EXCLUSIVE: 80 of the most common adverse events reported after Covid-19 vaccination Read More »
Sen. Ron Johnson (R-Wisconsin) has written a pointed letter to top U.S. medical authorities asking why they seem to be ignoring one of the most important factors in the Covid-19 pandemic: natural immunity. The Centers for Disease Control (CDC) estimates
The Chairman and CEO of Pfizer, maker of one of the Covid-19 vaccines used in the U.S., says it will likely take more than just vaccines to defeat Covid-19. Albert Bourla is touting a new experimental anti-viral drug under study
The FDA faces a court deadline of tomorrow, September 9, to issue Premarket Tobacco Product Application (PTPA) orders for every brand of e-cigarette on the market. The Covid shutdowns led to an extension to the original deadline. It may sound
According to reports, the departure of two lead FDA vaccine officials marks a dispute between FDA and CDC Some inside FDA have reportedly complained that CDC has improperly jumped ahead of FDA on some contentious Covid-19 vaccine issues, such as
The FDA has approved a new drug from Astra Zeneca to treat some patients with systemic lupus erythematosus (SLE). It’s the first approved drug of its kind, and the only new treatment for SLE in more than a decade, according
(READ) FDA approves new drug for autoimmune lupus disorder SLE Read More »
The FDA has issued a safety alert on Pepaxto, a cancer drug approved under an accelerated process to treat multiple myeloma. The drug is called melphalan flufenamide. According to the FDA, Pepaxto causes an increased risk of death. Read the
